astemizole has been researched along with wortmannin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Borowiec, AS; Gouilleux, F; Guénin, S; Guerineau, F; Hague, F; Harir, N; Lassoued, K; Ouadid-Ahidouch, H; Roudbaraki, M | 1 |
2 other study(ies) available for astemizole and wortmannin
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation.
Topics: Androstadienes; Astemizole; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Ether-A-Go-Go Potassium Channels; Female; Humans; Insulin-Like Growth Factor I; Ion Channel Gating; Membrane Potentials; Mitogen-Activated Protein Kinases; Phenolsulfonphthalein; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Potassium; Potassium Channel Blockers; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinidine; RNA Interference; RNA, Messenger; RNA, Small Interfering; Serum; Signal Transduction; Time Factors; Wortmannin | 2007 |